Xiong Qin
Nanning, 530021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
METTL3-mediated m6A modification of CACNA1E promotes osteosarcoma progression and chemoresistance by enhancing WNT7B-mediated Ca2+ signaling.
Journal: Molecular cancer
Published: July 13, 2025
Mapping the Multifaceted Roles of ZNF280A: Insights into Prognosis, Immunity, and Function Across Pan-Cancer.
Journal: Current medicinal chemistry
Published: October 08, 2024
Hsa_circ_0002005 aggravates osteosarcoma by increasing cell proliferation, migration, and invasion.
Journal: Gene
Published: June 27, 2024
Exploration of the combined role of immune checkpoints and immune cells in the diagnosis and treatment of ankylosing spondylitis: a preliminary study immune checkpoints in ankylosing spondylitis.
Journal: Arthritis research & therapy
Published: January 16, 2024
Hsa_circ_0007031 promotes the proliferation and migration of osteosarcoma cells by sponging miR-196a-5p to regulate the HOXB6.
Journal: Biochemical pharmacology
Published: April 12, 2023
Identification of Candidate MicroRNA-mRNA Subnetwork for Predicting the Osteosarcoma Progression by Bioinformatics Analysis.
Journal: Computational and mathematical methods in medicine
Published: February 16, 2022
Analysis and identification of m6A RNA methylation regulators in metastatic osteosarcoma.
Journal: Molecular therapy. Nucleic acids
Published: April 05, 2021
LncRNA UCA1 accelerates osteosarcoma progression via miR-145 and Wnt/β-catenin pathway.
Journal: American journal of translational research
Published: March 29, 2021
Integrative findings indicate anti-tumor biotargets and molecular mechanisms of calycosin against osteosarcoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 05, 2020
miR-17-5p Regulates Heterotopic Ossification by Targeting ANKH in Ankylosing Spondylitis.
Journal: Molecular therapy. Nucleic acids
Published: August 22, 2019
BTN3A2 serves as a prognostic marker and favors immune infiltration in triple-negative breast cancer.
Journal: Journal of cellular biochemistry
Published: July 14, 2019
Significance of circulating tumor cells in osteosarcoma patients treated by neoadjuvant chemotherapy and surgery.
Journal: Cancer management and research
Published: September 22, 2018
Last Updated: 09/26/2026